• Skip to main content
  • Skip to primary sidebar

Gold Coast Health & Knowledge Precinct

Transform with us

  • Home
  • About Us
    • Strategic Plan
    • Partners
      • City of Gold Coast
      • Griffith University
      • Gold Coast Health
      • Economic Development Queensland
      • Gold Coast Private Hospital
      • Cohort
      • Southport Sharks
    • Our people
    • Precinct Office
    • Map
    • Contact Us
  • Do Business
    • Investment Incentives
  • Live & Play
    • Australia’s Gold Coast
    • Residential – Smith Collective
    • Lifestyle – Retail and Recreation
  • Work & Study
  • Projects
    • Projects Overview
    • ADaPT
    • Clinical Entrepreneurship Change Agents Program
    • NeuTex Image-guided Surgery and Robotics Training Centre
  • Research
    • Overview
      • Additive Manufacturing
      • Biotechnologies
    • Research Institutes and Centres
    • Precinct experts
    • Research Equipment & Facilities
    • Clinical Trials
    • Health and medical training and conference hub
  • News
    • Latest News
    • Newsletter
    • Media
    • Video Channel
  • 中文
    • English
    • 中文

Filed Under: BUSINESS, HEALTH, INVEST, People of the Precinct, PROJECTS, STUDY, TECHNOLOGY Tagged With: Cohort, Gold Coast, Incubator, Student

Student innovation incubator set to launch in 2025

Cohort, located in the Gold Coast Health and Knowledge Precinct

Student innovation incubator set to launch in 2025

The NextGen Incubator, a new three-year student entrepreneurship program, is set to launch in the Gold Coast Health and Knowledge Precinct in 2025, following the recent funding announcement by the Queensland Government.

The student incubator will support entrepreneurial pathways for students and young innovators on the Gold Coast, tailored to bridge the gap between formal education and real-world entrepreneurship.

Craig Rowsell, Director of the Gold Coast Health and Knowledge Precinct welcomed the new initiative, which will be delivered by CoSpaces in the Precinct’s Cohort space, in collaboration with Griffith University.

“This initiative will ensure that the next generation of entrepreneurs have the support they need to commercialise their ideas and create new businesses in the Gold Coast Health and Knowledge Precinct,” Craig said.

“Cohort is the perfect place for young innovators to start their business journey – the co-working space, located in the heart of the Precinct, already supports a new generation of innovators, and is a launchpad for health and technology start-ups.

“The students will have the chance to meet and learn from some of the top talent who work in the Precinct, providing them with a solid foundation to chase their entrepreneurial dreams.”

The NextGen Incubator will offer hands-on workshops, coaching, a pre-accelerator program, 1:1 mentoring, and networking opportunities with industry leaders and investors. Participants will also gain access to events such as pitch nights, hackathons, and expert panels.

CoSpaces CEO Ben Howe said the team had identified a strong need for a program of this kind on the Gold Coast.

“The incubator will not only benefit young people and students, but many other regional stakeholders including startups, academia and the ecosystem organisations,” Ben said.

“By accelerating student and youth pathways into entrepreneurship, the incubator will foster collaboration between students and industry, provide mentorship to bring innovative new products to commercialisation stage, and accelerate the regional adoption of entrepreneurship on the Gold Coast.”

The NextGen Incubator project has received $300,000 funding under the Queensland Government’s Advance Queensland’s Regional Enablers Program (REP) and will run from 2025 to 2028. Information on how to apply to be part of the program will be released in the coming months.

October 30, 2024 By Gemma Bull

Filed Under: HEALTH, People of the Precinct, PROJECTS, TECHNOLOGY Tagged With: Clinical Trial, Gold Coast, Griffith University, James St John, nerve bridge, World first

World-first clinical trial for treating spinal cord injury

James St John at Griffith University

World-first clinical trial for treating spinal cord injury

A world-first clinical trial that could revolutionise the treatment of spinal cord injuries has been announced.

The trial combines nerve bridge therapy with patient-centred rehabilitation, aiming to restore independence for individuals affected by spinal cord injury.

This breakthrough represents a significant advancement in translating cutting-edge research into clinical practice, offering new hope to those living with these life-changing injuries.

Griffith University researcher, Professor James St John and his team from the Clem Jones Centre for Neurobiology and Stem Cell Research said olfactory ensheathing cells are the specialised cells within the olfactory (sense of smell) nerve within the nose that have numerous therapeutic properties for repairing and regenerating nerves.

“With more than 20,000 Australians living with spinal cord injury, and another 300 or more people having spinal cord injury each year, now is the time to translate this therapy into the clinic,” Professor St John said.

“We have designed the trial in close consultation with the spinal injury community, clinicians and industry partners to ensure the trial meets the needs and expectations of the trial participants, and has the best chance of success.”

The trial is funded by the Medical Research Future Fund, Perry Cross Spinal Research Foundation, The Clem Jones Foundation, Queensland Government, Nicola and Andrew Forrest, Brazil Family Foundation, Terry and Rhonda White, and Griffith University.

Find out more on the Griffith University website

October 22, 2024 By Gemma Bull

Filed Under: HEALTH, People of the Precinct, PROJECTS, TECHNOLOGY Tagged With: Australia, BiVACOR, City of Gold Coast, Daniel Timms, Gold Coast, The Australian, top 100, Total artificial heart

Australian-designed Total Artificial Heart amongst The Australian’s Top 100

BiVACOR's Daniel Timms

Inventor of BiVACORs Total Artificial Heart makes The Australian's Top 100

Dr Daniel Timms, a biomedical engineer from Brisbane, has landed on this years’ The Australian Top 100 Innovators List, for his Australian-designed BiVACOR Total Artificial Heart. The list names leading innovators in their fields, celebrating the ambition and commitment of the nation’s newest entrepreneurs.

BiVACOR is a clinical-stage medical device company developing the Total Artificial Heart (TAH), the first long-term solution for patients with severe heart failure.

The BiVACOR TAH could become the world’s first permanent artificial heart replacement after being developed by Dr Daniel Timms and his father Gary, who was dying of heart failure.

In a successful FDA-approved Early Feasibility Study trial conducted in Texas in early July, the 650g titanium pump was implanted for eight days in a patient. They have since gone on to complete numerous other trials, in one case keeping a young father alive for just short of a month before a donor heart became available.

The BiVACOR TAH promises to last longer than other artificial hearts because it uses a single spinning disc to push blood around the body. The disc is magnetically levitated within its chamber, minimising wear and tear. This design will revolutionise the heart failure field and see the delivery of a life-long alternative to organ donation.

BiVACOR has received $50m in funding from the Australian government this year, while the Medical Research Future Fund has backed a trial in Australian patients.

BiVACOR’s Research and Development arm is based in the Gold Coast Health and Knowledge Precinct. From there, they have been collaborating with Griffith University’s world-class Mechanobiology Research Laboratory which has been performing advanced laboratory testing on the total artificial heart.

“Coming back from the US, where we work very closely with the world-renowned Texas Heart Institute, to see the expansion of the Gold Coast Health and Knowledge Precinct made it really attractive for us to bring our technology back here to work with a world-leading laboratory at Griffith.”

DANIEL TIMMS, Founder and CTO, BiVACOR

October 22, 2024 By Gemma Bull

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 14
  • Go to Next Page »

Primary Sidebar

Recent Posts

  • From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort
  • A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast
  • Clinician Entrepreneurship Program wraps as a big success
  • 2025 International Women’s Day
  • International Women’s Day event 2025
  • Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research
  • INVEST-FEST accelerates founder funding
  • Student innovation incubator set to launch in 2025
  • World-first clinical trial for treating spinal cord injury
  • Australian-designed Total Artificial Heart amongst The Australian’s Top 100

Archives

  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • May 2024
  • April 2024
  • January 2024
  • December 2023
  • October 2023
  • September 2023
  • August 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • October 2022
  • August 2022
  • July 2022
  • May 2022
  • March 2022
  • February 2022
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018

Subscribe to our newsletter and we’ll update you on all that’s new in our Precinct.

Latest News

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort image

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort

Read More >

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast image

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast

Read More >

Clinician Entrepreneurship Program wraps as a big success image

Clinician Entrepreneurship Program wraps as a big success

Read More >

2025 International Women's Day image

2025 International Women's Day

Read More >

International Women's Day event 2025 image

International Women's Day event 2025

Read More >

Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research image

Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research

Read More >

Before Footer

Search

Asia-Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health & Knowledge Precinct (GCHKP) is a unique global business location for high-tech industry development, research collaboration and jobs of the future.

  • Home
  • About Us
  • Precinct Map
  • News
  • Do Business
  • Work & Study
  • Partners
  • Projects
  • Research
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Subscribe
  • Facebook
  • LinkedIn
  • YouTube

© 2025 Gold Coast Health and Knowledge Precinct. All rights reserved.

Designed and Developed by Stead Lane